NCT05447923 Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
| NCT ID | NCT05447923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Colorectal Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 450 participants |
| Start Date | 2022-05-22 |
| Primary Completion | 2030-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 450 participants in total. It began in 2022-05-22 with a primary completion date of 2030-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.
Eligibility Criteria
Inclusion Criteria: * Age 45 years of age or older * No prior history of colorectal cancer or colon polyps * No first-degree family history of colorectal cancer who were diagnosed under age 60 * No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding) * Have not undergone a colonoscopy in the last 5 years * Have not had a fecal immunochemical test (FIT) test within the last year * Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area
Contact & Investigator
Juliana M. Kling, MD, MPH
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05447923 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Colorectal Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05447923 currently recruiting?
Yes, NCT05447923 is actively recruiting participants. Contact the research team at Parker.Yahaira@mayo.edu for enrollment information.
Where is the NCT05447923 trial being conducted?
This trial is being conducted at Scottsdale, United States.
Who is sponsoring the NCT05447923 clinical trial?
NCT05447923 is sponsored by Mayo Clinic. The principal investigator is Juliana M. Kling, MD, MPH at Mayo Clinic. The trial plans to enroll 450 participants.